MMP9 Rat

Matrix Metalloproteinase-9 Rat Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to MMP9 in Rats

Matrix metalloproteinase-9 (MMP-9), also known as gelatinase B, is a zinc-dependent endopeptidase critical for extracellular matrix (ECM) remodeling. In rats, MMP-9 plays pivotal roles in physiological processes and pathological conditions, including cardiovascular remodeling, neuroinflammation, and cancer progression. Its expression is tightly regulated, and dysregulation is implicated in diseases such as atherosclerosis, traumatic brain injury (TBI), and stroke .

Cardiovascular System

  • Vascular Remodeling: Overexpression in Fischer rats enhances smooth muscle cell (SMC) migration, leading to luminal dilation and reduced extracellular matrix content post-injury .

  • Atherosclerosis and Aneurysms: Elevated MMP-9 activity promotes plaque instability and aneurysm formation. Inhibition via doxycycline reduces aortic inflammation and aneurysm growth .

Neurological Disorders

  • Cerebral Ischemia: MMP-9 expression peaks 24 hours post-middle cerebral artery occlusion (MCAO), localizing to endothelial cells and neutrophils. Inhibition reduces infarct size .

  • Traumatic Brain Injury (TBI): MMP-9 levels rise post-injury, correlating with edema and neuronal damage. Minocycline administration reduces MMP-9 by 9.5% in Wistar rats, mitigating injury severity .

  • Epilepsy: MMP-9 knockout rats exhibit reduced seizure susceptibility, while overexpression accelerates epileptogenesis .

Cancer and Metastasis

  • Tumor Progression: MMP-9 facilitates angiogenesis and ECM degradation, promoting metastasis. Its activity is modulated by chemokine cleavage (e.g., CXCL12 degradation) .

Research Findings from Rat Models

ModelKey FindingsCitation
Vascular InjuryMMP-9 overexpression increases SMC migration and luminal dilation. BB-94 inhibition reverses these effects.
Cerebral IschemiaMMP-9 colocalizes with endothelial cells and neutrophils at 24 hours post-MCAO. Neutralizing antibodies reduce infarct size.
TBIMMP-9 levels rise from 0.519 ng/mL (control) to 0.610 ng/mL post-injury. Minocycline reduces MMP-9 to 0.552 ng/mL.
AtherosclerosisHigh-fat diet rats show elevated aortic MMP-9 and osteoclast activity, linking cardiovascular and bone diseases.
EpileptogenesisMMP-9 knockout rats require longer kindling periods to induce seizures. Overexpression accelerates mossy fiber sprouting.

Therapeutic Interventions Targeting MMP9 in Rats

InterventionMechanismOutcomeCitation
MinocyclineInhibits MMP-9 via antioxidant effects.Reduces TBI-induced MMP-9 by 9.5% and improves recovery.
BB-94 (Inhibitor)Blocks MMP-9 catalytic activity.Reverses vascular SMC migration and remodeling.
DoxycyclineReduces MMP-9 expression and inflammation.Suppresses aortic aneurysm growth.

Comparative Analysis: Human vs. Rat MMP9

FeatureHuman MMP9Rat MMP9
Pro-domainCysteine residue (binds lipocalin)Serine residue (altered binding)
Linker DomainShorter, less glycosylationLonger, 23 additional amino acids
Molecular Weight92 kDa (pro), 88 kDa (active)105 kDa (pro), 95 kDa (active)
Neurological RoleSynaptic remodeling, neuroinflammationEpileptogenesis, TBI recovery

Product Specs

Description
MMP9 Rat, produced in HEK293 cells, is a single, glycosylated polypeptide chain containing 695 amino acids (amino acids 20-708). It has a molecular mass of 77.2 kDa. MMP9 is expressed with a 6 amino acid His tag at the C-terminus and purified by proprietary chromatographic techniques.
Physical Appearance
Sterile filtered colorless solution.
Formulation
MMP9 Rat protein solution (0.5 mg/ml) contains 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM CaCl2, and 10% glycerol.
Stability
Store at 4°C if the entire vial will be used within 2-4 weeks. For longer storage, freeze at -20°C. For long term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Biological Activity
> 2000 pmol/min/ug, defined as the amount of enzyme which cleaves 1 pmol of Mca-PLGLDpa-AR-NH2/min at pH 7.5 at 25°C.
Synonyms

Matrix metalloproteinase-9, MMP-9, 92 kDa gelatinase, Gelatinase B, GELB, MMP9, CLG4B.

Source

HEK293 Cells.

Amino Acid Sequence

APHQRQPTYV VFPRDLKTSN LTDTQLAEDY LYRYGYTRAA QMMGEKQSLR PALLMLQKQL SLPQTGELDS ETLKAIRSPR CGVPDVGKFQ TFEGDLKWHH HNITYWIQSY TEDLPRDVID DSFARAFAVW SAVTPLTFTR VYGLEADIVI QFGVAEHGDG YPFDGKDGLL AHAFPPGPGI QGDAHFDDDE LWSLGKGAVV PTYFGNANGA PCHFPFTFEG RSYLSCTTDG RNDGKPWCGT TADYDTDRKY GFCPSENLYT EHGNGDGKPC VFPFIFEGHS YSACTTKGRS DGYRWCATTA NYDQDKLYGF CPTRADVTVT GGNSAGEMCV FPFVFLGKQY STCTGEGRSD GRLWCATTSN FDADKKWGFC PDQGYSLFLV AAHEFGHALG LDHSSVPEAL MYPMYHYHED SPLHEDDIKG IQHLYGRGSK PDPRPPATTA AEPQPTAPPT MCPTAPPMAY PTGGPTVAPT GAPSPGPTGP PTAGPSEAPT ESSTPVDNPC NVDVFDAIAD IQGALHFFKD GRYWKFSNHG GSQLQGPFLI ARTWPALPAK LNSAFEDPQS KKIFFFSGRK MWVYTGQTVL GPRSLDKLGL GSEVTLVTGL LPRRGGKALL ISRERIWKFD LKSQKVDPQS VTRLDNEFSG VPWNSHNVFH YQDKAYFCHD KYFWRVSFHN RVNQVDHVAY VTYDLLQCPH HHHHH.

Product Science Overview

Introduction

Matrix Metalloproteinase-9 (MMP-9), also known as gelatinase B, is a member of the matrix metalloproteinase (MMP) family. These enzymes are zinc and calcium-dependent endopeptidases capable of degrading various components of the extracellular matrix (ECM), such as collagen, elastin, and proteoglycans . MMP-9 is particularly notable for its role in both physiological and pathological processes, including tissue remodeling, inflammation, and cancer metastasis .

Structure and Activation

MMP-9 is initially produced as an inactive zymogen (proMMP-9) that requires activation to become enzymatically functional . The activation process involves the cleavage of the pro-domain, which masks the catalytic site of the enzyme. This cleavage can be mediated by other proteases, oxidative modifications, or conformational changes due to substrate binding .

Biological Functions

MMP-9 plays a crucial role in various biological processes:

  • Tissue Remodeling: MMP-9 is involved in the degradation of ECM components, facilitating tissue remodeling and repair .
  • Inflammation: MMP-9 is upregulated during inflammatory responses and contributes to the migration of leukocytes to the site of inflammation by degrading basement membrane components .
  • Neuroinflammation and Cerebral Ischemia: MMP-9 is actively involved in blood-brain barrier disruption following cerebral ischemia and neuroinflammation .
  • Synaptic Plasticity and Memory: In the brain, MMP-9 is required for hippocampal late-phase long-term potentiation (L-LTP) and memory formation .
Pathological Implications

MMP-9 is implicated in several pathological conditions:

  • Cancer: MMP-9 facilitates cancer cell invasion and metastasis by degrading ECM barriers .
  • Cardiovascular Diseases: MMP-9 contributes to the atherogenic environment of the vessel wall and is involved in the regulation of cytokine production and macrophage function .
  • Bone Diseases: MMP-9 plays a regulatory role in osteoclastogenesis, linking cardiovascular diseases and bone disorders in high-fat diet-fed rats .
Recombinant MMP-9

Recombinant MMP-9 (Rat) is a laboratory-produced version of the enzyme, often used in research to study its functions and interactions. The recombinant form allows for controlled experiments to understand the enzyme’s role in various biological and pathological processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.